Clinical significance of the neutrophil-lymphocyte ratio as an early predictive marker for adverse outcomes in patients with acute pancreatitis

Table 4 Area under curve (95%CI) value for predicting disease severity, development of organ failure, necrosis, local complications, ICU admission and mortality

	Severity	Organ failure	Necrosis	Local Cx	ICU adm	Mortality
NLR 0	0.59a (0.52-0.66)	0.62a (0.51-0.72)	0.52 (0.44-0.60)	0.54 (0.48-0.60)	0.58 (0.47-0.70)	0.44 (0.21-0.67)
NLR 1	0.62a (0.55-0.69)	0.66a (0.55-0.77)	0.60a (0.52-0.68)	0.57 (0.51-0.63)	0.73a (0.63-0.83)	0.62 (0.38-0.85)
NLR 2	0.62a (0.55-0.70)	0.66a (0.55-0.78)	0.61a (0.53-0.69)	0.59a (0.53-0.66)	0.74a (0.64-0.84)	0.60 (0.30-0.85)
NLR 3	0.62a (0.55-0.70)	0.67a (0.56-0.79)	0.59a (0.51-0.66)	0.60a (0.54-0.67)	0.73a (0.63-0.83)	0.62 (0.39-0.85)

NLR 0, baseline neutrophil-lymphocyte ratio; NLR 1, on day 1; NLR 2, on day 2; NLR 3, on day 3;

^aP value < 0.05. Cx: Complications; adm: Admission; NLR: Neutrophil-lymphocyte ratio.